Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Davis, S. orcid.org/0000-0002-6609-4287, Rafia, R. orcid.org/0000-0002-6914-1990, Carroll, C. orcid.org/0000-0002-6361-6182 et al. (2 more authors) (2018) Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer Nature Switzerland AG 2018. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy. The final publication is available at Springer via https://doi.org/10.1007/s40273-018-0727-1.
Dates:
  • Published: 22 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 31 Oct 2018 15:05
Last Modified: 22 Oct 2019 00:39
Published Version: https://doi.org/10.1007/s40273-018-0727-1
Status: Published online
Publisher: Springer
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-018-0727-1
Related URLs:

Share / Export

Statistics